We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use 51²è¹Ý, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Overview of the UK's cell and gene therapy research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Overview of the UK's orthopaedics research infrastructure and advantages of investment in the UK's life science sector to support new treatments and technology.
Overview of the UK's cancer research infrastructure and the advantages of investing in the UK's life science sector to develop new treatments.
We help UK life sciences companies to do business overseas and support foreign life sciences companies to invest in the UK.
Overview of UK research infrastructure to develop new medical technology and advantages of investment in the UK's life science sector to support new products.
Dr Liam Fox opinion editorial in the Sunday Telegraph on how the UK is leading innovation and technological change in the life sciences sector.
First published during the 2016 to 2019 May Conservative government
Overview of the UK's medical imaging infrastructure and advantages of investment in the UK's life science sector to develop new technology.
Welsh Secretary: “Investment is a real vote of confidence in Wales’ growing stature as a hotbed of life sciences expertise".
Twenty one life sciences companies will join DIT on a trade mission to the world-renowned conference in Boston today.
Overview of UK research infrastructure for genomics technologies, and advantages of investment in the UK's life science sector to support new products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve 51²è¹Ý, we’d like to know more about your visit today. .